| 000 | 00977 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516113515.0 | ||
| 264 | 0 | _c20130228 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1090-2430 | ||
| 024 | 7 |
_a10.1016/j.expneurol.2012.09.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRidder, Dirk A | |
| 245 | 0 | 0 |
_aTAK1 inhibition for treatment of cerebral ischemia. _h[electronic resource] |
| 260 |
_bExperimental neurology _cJan 2013 |
||
| 300 |
_a68-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain Ischemia _xenzymology |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aZearalenone _xanalogs & derivatives |
| 700 | 1 | _aSchwaninger, Markus | |
| 773 | 0 |
_tExperimental neurology _gvol. 239 _gp. 68-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2012.09.010 _zAvailable from publisher's website |
| 999 |
_c22145216 _d22145216 |
||